Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma

被引：4
|
作者：
Labaki, Chris [1 ,2 ]
Saliby, Renee Maria [1 ]
Bakouny, Ziad [1 ,3 ]
Saad, Eddy [1 ]
Semaan, Karl [1 ]
Eid, Marc [1 ]
Lalani, Aly-Khan [4 ]
Choueiri, Toni K. [1 ]
Braun, David A. [5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA USA
[4] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[5] Yale Sch Med, Ctr Mol & Cellular Oncol CMCO, New Haven, CT USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 05期
关键词：
Renal cell carcinoma; Biomarkers; Systemic therapy; Immunotherapy; Targeted therapy; MOLECULAR SUBTYPES; 1ST-LINE TREATMENT; CHECKPOINT; SUNITINIB;
D O I：
10.1016/j.hoc.2023.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [41] Pharmacotherapy for treating metastatic clear cell renal cell carcinoma
    Porta, Camillo
    Chiellino, Silvia
    Ferrari, Alessandra
    Mariucci, Sara
    Liguigli, Wanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 205 - 216
  • [42] Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma
    Lalani, Aly-Khan A.
    Xie, Wanling
    Braun, David A.
    Kaymakcalan, Marina
    Bosse, Dominick
    Steinharter, John A.
    Martini, Dylan J.
    Simantov, Ronit
    Lin, Xun
    Wei, Xiao X.
    McGregor, Bradley A.
    McKay, Rana R.
    Harshman, Lauren C.
    Choueiri, Toni K.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (03): : 372 - 381
  • [43] Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review
    Zarba, Martin
    Fujiwara, Ryo
    Yuasa, Takeshi
    Koga, Fumitaka
    Heng, Daniel Y. C.
    Takemura, Kosuke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (08) : 693 - 703
  • [44] Update on systemic therapy for clear cell renal cell carcinoma
    Josef Mühlmann
    memo - Magazine of European Medical Oncology, 2023, 16 : 38 - 41
  • [45] Update on systemic therapy for clear cell renal cell carcinoma
    Muehlmann, Josef
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (01) : 38 - 41
  • [46] Sequencing Therapies for Metastatic Renal Cell Carcinoma
    Dizman, Nazli
    Arslan, Zeynep E.
    Feng, Matthew
    Pal, Sumanta K.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 305 - +
  • [47] Systemic adjuvant therapies in renal cell carcinoma
    Buti, Sebastiano
    Bersanelli, Melissa
    Donini, Maddalena
    Ardizzoni, Andrea
    ONCOLOGY REVIEWS, 2012, 6 (02) : 145 - 152
  • [48] Combination therapies in non-clear-cell renal cell carcinoma
    Aslan, Volkan
    Ozdemir, Nuriye
    Yazici, Ozan
    Ozet, Ahmet
    LANCET ONCOLOGY, 2023, 24 (10): : E401 - E401
  • [49] Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma
    Marta, Guilherme Nader
    Velho, Pedro Isaacsson
    Bonadio, Renata R. C.
    Nardo, Mirella
    Faraj, Sheila F.
    de Azevedo Souza, Manoel Carlos L.
    Muniz, David Q. B.
    Bastos, Diogo Assed
    Dzik, Carlos
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2489 - 2497
  • [50] A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma
    Ismail, Salima
    Meskawi, Malek
    Hansen, Jens
    Bianchi, Marco
    Tian, Zhe
    Latour, Mathieu
    Graefen, Markus
    Montorsi, Francesco
    Quoc-Dien Trinh
    Perrotte, Paul
    Karakiewicz, Pierre I.
    Sun, Maxine
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 90 (01) : 49 - 57
12345